IRulya Therapeutics Inc 10-Q for FY2023 Q2
IRulya Therapeutics Inc. (IRLA)
10-Q
2023-08-03
For: 2023-06-30
View Original
Added on
April 05, 2026
About this 10-Q
IRulya Therapeutics Inc filed this 10-Q on August 3, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $4.89M
- compared with a net loss of $16.56M a year earlier
- Diluted EPS
- -$0.14
- compared with -$0.51 a year earlier